| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | IRMD Iradimed Corporation | Susi Roger E.53 | CEO, President, Chairman | Sell | 7,500 | $85.71 | $642,861.82 | - | - | - | |
| May 4, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J.62 | Cvp, Tavr | Sell | 2,038 | $83.49 | $170,160.29 | -1.9% | - | - | |
| May 1, 2026 | BFLY Butterfly Network, Inc. | Carlson Megan | CAO And SVP, Finance | Sell | 110,422 | $4.75 | $524,394.08 | -17.9% | - | - | |
| May 1, 2026 | CBLL Ceribell, Inc. | Woo Raymond | Chief Technology Officer | Sell | 11,104 | $20.44 | $226,928.18 | -1.8% | - | - | |
| May 1, 2026 | AVTR Avantor, Inc. | Dingemans Simon | Director | Buy | 25,000 | $8.14 | $203,500.00 | New | - | - | |
| May 1, 2026 | GEHC Ge Healthcare Technologies Inc. | Saccaro James | Chief Financial Officer | Buy | 3,310 | $60.60 | $200,585.01 | +3.9% | - | - | |
| Apr 29, 2026 | BFLY Butterfly Network, Inc. | Cashman Steve | Chief Business Officer | Sell | 147,518 | $4.91 | $724,165.86 | -6.8% | - | - | |
| Apr 29, 2026 | ISRG Intuitive Surgical, Inc. | Ladd Amy L55 | Director | Sell | 619 | $471.55 | $291,886.50 | -63.3% | - | - | |
| Apr 27, 2026 | BDX Becton, Dickinson And Company | Feld Michael | EVP, Chief Revenue Officer | Sell | 74 | $151.94 | $11,243.56 | -0.3% | - | - | |
| Apr 27, 2026 | ABT Abbott Laboratories | Starks Daniel J53 | Director | Buy | 10,000 | $92.65 | $926,537.00 | +0.1% | - | - | |
| Apr 27, 2026 | ESTA Establishment Labs Holdings Inc. | Chacon Quiros Juan Jose48 | Director | Sell | 75,000 | $65.59 | $4,919,477.85 | -0.7% | - | - | |
| Apr 23, 2026 | ABT Abbott Laboratories | Boudreau Philip P66 | EVP And CFO | Buy | 2,200 | $91.50 | $201,300.00 | New | - | - | |
| Apr 21, 2026 | RGEN Repligen Corporation | Loeillot Olivier | Chief Executive Officer | Sell | 3,832 | $140.00 | $536,480.00 | -6.6% | - | - | |
| Apr 21, 2026 | STIM Neuronetics, Inc. | Chernett Jorey | 10% Owner | Buy | 200,000 | $1.55 | $309,000.00 | +1.0% | - | - | |
| Apr 21, 2026 | SNWV Sanuwave Health, Inc. | Opaleye Management Inc.59 | 10% Owner | Sell | 16,469 | $20.46 | $336,982.22 | -0.9% | - | - | |
| Apr 20, 2026 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 100,000 | $24.67 | $2,467,129.65 | -33.3% | - | - | |
| Apr 15, 2026 | DXCM Dexcom, Inc. | Brown Michael Jon72 | EVP, Chief Legal Officer | Sell | 1,700 | $63.04 | $107,168.00 | -1.5% | - | - | |
| Apr 14, 2026 | IRMD Iradimed Corporation | Susi Roger E.53 | CEO, President, Chairman | Sell | 7,500 | $92.96 | $697,189.21 | - | - | - | |
| Apr 10, 2026 | MASS 908 Devices Inc. | McCallion Kevin J. | SVP, Products And Production | Sell | 2,693 | $7.01 | $18,877.93 | -5.7% | - | - | |
| Apr 10, 2026 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Former Officer And Director | Sell | 16,072 | $6.02 | $96,753.44 | -5.2% | - | - | |
| Apr 10, 2026 | MASS 908 Devices Inc. | Brown Christopher D.85 | Director | Sell | 40,000 | $7.06 | $282,277.64 | -1.4% | - | - | |
| Apr 9, 2026 | EW Edwards Lifesciences Corporation | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 13,000 | $80.04 | $1,040,544.36 | -12.9% | - | - | |
| Apr 9, 2026 | MASS 908 Devices Inc. | McCallion Kevin J. | SVP, Products And Production | Sell | 24,000 | $7.05 | $169,091.60 | -21.1% | - | - | |
| Apr 8, 2026 | DXR Daxor Corporation | Feldschuh Michael Richard75 | Chief Executive Officer | Buy | 1,000 | $9.07 | $9,070.00 | +0.5% | - | - | |
| Apr 7, 2026 | RSMDF Resmed Inc. | Farrell Michael J.62 | Chairman And CEO | Sell | 4,991 | $225.50 | $1,125,486.47 | -1.1% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.